- About Us
- Be a Contributor
- Cart
- Checkout
- Connect with Pharm SO Hard
- Contact Us
- EM Pharmacy Service Map
- Emergency Medicine Map Directory
- Home
- Homepage
- Merch
- My account
- Pharm So Hard Podcast Host/Contributor Application Form
- Podcast Episodes
- Shop
- Home 2
- Blog Feed
To view the handout for the Pharmacy Friday Pearl visit: https://www.pharmacy-pearls.com/home
Introduction
- Insulin with dextrose is an effective method to lower potassium levels quickly in acute hyperkalemia
- Literature shows ranges of potassium reduction by 0.5-1.0 mEq after administration of a single dose.
- Patients with renal insufficiency and end-stage renal disease (ESRD) have a higher incidence of hypoglycemia after treatment with insulin for hyperkalemia due to:
- Reduced insulin clearance (prolonged insulin action)
- Reduced hepatic glucose production
- Reduced renal gluconeogenesis
The appropriate dose of insulin to minimize hypoglycemic events when using for the treatment of hyperkalemia in patients with renal insufficiency is still debated.
Tweet
Pharmacology
Regular Insulin
Mechanism | Cause an intracellular shift of potassium via exchange of sodium ions via the Na+/K+ ATPase pump |
Dose | 5-10 units Doses of 0.1 units/kg (max 10 units) have also been considered |
Administration | IV push |
PK/PD | Onset: 15-30 minutes for initial potassium lowering effects Duration: 4-6 hours, prolonged duration in ESRD |
Adverse Effects | Hypoglycemia, hypokalemia, hypersensitivity |
Compatibility | Can dilute in normal saline to increase volume for ease of administration |
Pearls | Must be given with dextrose (25g IV) to prevent hypoglycemia —–Some patients require repeated dextrose; rare exceptions for those already extremely hyperglycemic The most commonly used product is regular human insulin given IV to ensure the fast onset of potassium lowering effects and prevent variable absorption |
#pharmsohard


Review of Evidence
Author, Year | Design (Sample Size) | Intervention & Comparison | Outcomes |
---|---|---|---|
Moussavi et al., 2021 | Meta-analysis (n = 3437) | 10 units vs <10 units IV regular insulin | • <10 units IV regular insulin had lower pooled odds of hypoglycemia odds ratio [OR] 0.55 and severe hypoglycemia OR 0.41 • No difference in potassium reduction was detected mean difference -0.02 mmol/L |
Verdier et al., 2021 | Single-center, retrospective (n =174) | 5 units vs 10 units IV regular insulin in ICU patients | • Hypoglycemia was more frequent with 10 units vs 5 units of IV insulin (19.5 vs 9.2%, p=0.052) • No difference in rates of severe hypoglycemia or change in serum potassium |
Moussavi et al conducted a Meta-analysis (n = 3437) that looked at 10 units vs <10 units IV regular insulin. They found that <10 units IV regular insulin had lower pooled odds of hypoglycemia odds ratio [OR] 0.55 and severe hypoglycemia OR 0.41
Tweet
Conclusion
- Hypoglycemia risk seems to be elevated in those patients with renal insufficiency, especially those who are insulin-naive
- Consideration should be made to lower the initial dose of IV insulin for patients with AKI or CKD
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Google Podcasts | RSS | http://pharmsohard.com/